that FR940405-1-00136 4 516 550 566 618
absorb FR940405-1-00136 1 517
uva FR940405-1-00136 8 518 537 555 560 589 611 615 657
radiation FR940405-1-00136 1 519
( FR940405-1-00136 4 520 580 595 660
58 FR940405-1-00136 2 521 596
fr FR940405-1-00136 2 522 597
28194 FR940405-1-00136 2 523 598
at FR940405-1-00136 2 524 599
28248 FR940405-1-00136 1 525
to FR940405-1-00136 8 526 536 548 577 587 608 632 644
28250 FR940405-1-00136 1 527
) FR940405-1-00136 4 528 582 601 664
. FR940405-1-00136 8 529 547 602 625 635 647 662 665
the FR940405-1-00136 6 530 563 603 623 636 650
comment FR940405-1-00136 1 531
period FR940405-1-00136 1 532
for FR940405-1-00136 1 533
comments FR940405-1-00136 2 534 640
related FR940405-1-00136 1 535
ingredients FR940405-1-00136 1 538
, FR940405-1-00136 6 539 541 546 562 627 649
claims FR940405-1-00136 3 540 557 591
and FR940405-1-00136 1 542
testing FR940405-1-00136 2 543 616
closed FR940405-1-00136 1 544
on FR940405-1-00136 3 545 641 656
ensure FR940405-1-00136 1 549
sunscreen FR940405-1-00136 2 551 569
drug FR940405-1-00136 1 552
products FR940405-1-00136 1 553
having FR940405-1-00136 1 554
protection FR940405-1-00136 5 556 561 590 612 658
offer FR940405-1-00136 1 558
significant FR940405-1-00136 1 559
agency FR940405-1-00136 3 564 637 651
proposed FR940405-1-00136 1 565
an FR940405-1-00136 2 567 573
otc FR940405-1-00136 1 568
ingredient FR940405-1-00136 1 570
must FR940405-1-00136 1 571
have FR940405-1-00136 3 572 607 630
absorption FR940405-1-00136 1 574
spectrum FR940405-1-00136 1 575
extending FR940405-1-00136 1 576
360 FR940405-1-00136 1 578
nanometers FR940405-1-00136 1 579
nm FR940405-1-00136 1 581
or FR940405-1-00136 1 583
above FR940405-1-00136 1 584
in FR940405-1-00136 3 585 592 622
order FR940405-1-00136 1 586
display FR940405-1-00136 1 588
its FR940405-1-00136 1 593
labeling FR940405-1-00136 1 594
28233 FR940405-1-00136 1 600
product FR940405-1-00136 1 604
would FR940405-1-00136 2 605 619
also FR940405-1-00136 1 606
demonstrate FR940405-1-00136 1 609
meaningful FR940405-1-00136 1 610
by FR940405-1-00136 1 613
satisfying FR940405-1-00136 1 614
procedures FR940405-1-00136 3 617 629 643
be FR940405-1-00136 3 620 633 645
included FR940405-1-00136 1 621
monograph FR940405-1-00136 1 624
however FR940405-1-00136 1 626
these FR940405-1-00136 1 628
yet FR940405-1-00136 1 631
established FR940405-1-00136 1 634
requested FR940405-1-00136 2 638 653
specific FR940405-1-00136 2 639 654
appropriate FR940405-1-00136 1 642
used FR940405-1-00136 1 646
previously FR940405-1-00136 1 648
had FR940405-1-00136 1 652
information FR940405-1-00136 1 655
factors FR940405-1-00136 1 659
ref FR940405-1-00136 1 661
1 FR940405-1-00136 1 663
in FR940405-1-00137 10 0 66 95 111 309 382 564 653 735 769
the FR940405-1-00137 50 1 14 24 78 96 100 112 117 144 165 190 194 216 241 272 292 319 329 392 410 422 428 432 436 446 460 465 482 485 495 501 519 535 548 559 565 577 588 629 636 641 650 664 688 713 729 742 752 760 776
proposed FR940405-1-00137 2 2 97
rule FR940405-1-00137 2 3 98
( FR940405-1-00137 18 4 32 71 126 130 136 233 247 264 451 454 568 581 602 683 691 697 706
58 FR940405-1-00137 1 5
fr FR940405-1-00137 1 6
28194 FR940405-1-00137 1 7
at FR940405-1-00137 8 8 506 515 522 531 538 542 551
28248 FR940405-1-00137 1 9
to FR940405-1-00137 18 10 23 40 63 87 257 335 472 476 490 570 583 598 646 660 724 750 771
28250 FR940405-1-00137 1 11
) FR940405-1-00137 18 12 36 73 128 138 140 235 261 266 453 458 573 586 606 685 693 699 708
, FR940405-1-00137 37 13 58 64 70 76 99 132 143 173 175 181 183 193 249 262 308 328 347 351 355 358 399 402 404 406 467 470 574 618 633 640 655 690 696 704 712 741
agency FR940405-1-00137 7 15 79 101 145 166 195 217
tentatively FR940405-1-00137 1 16
suggested FR940405-1-00137 1 17
that FR940405-1-00137 23 18 42 103 160 197 211 307 333 368 413 431 500 514 530 558 611 632 671 716 745 763 775 781
a FR940405-1-00137 9 19 43 89 104 168 277 311 324 383
testing FR940405-1-00137 8 20 119 139 153 185 205 268 757
method FR940405-1-00137 4 21 54 90 105
similar FR940405-1-00137 1 22
one FR940405-1-00137 4 25 304 365 668
described FR940405-1-00137 3 26 394 492
by FR940405-1-00137 6 27 276 323 445 576 678
lowe FR940405-1-00137 1 28
et FR940405-1-00137 1 29
al FR940405-1-00137 1 30
. FR940405-1-00137 29 31 34 52 74 141 164 187 228 303 341 364 391 409 427 456 459 494 518 534 554 587 604 607 628 667 710 739 759 787
ref FR940405-1-00137 3 33 455 603
2 FR940405-1-00137 3 35 265 692
could FR940405-1-00137 1 37
be FR940405-1-00137 7 38 107 213 336 339 767 779
used FR940405-1-00137 1 39
demonstrate FR940405-1-00137 1 41
sunscreen FR940405-1-00137 6 44 118 133 157 278 325
drug FR940405-1-00137 5 45 158 279 326 349
product FR940405-1-00137 3 46 280 327
provides FR940405-1-00137 1 47
protection FR940405-1-00137 12 48 94 122 134 163 210 274 321 613 625 765 773
against FR940405-1-00137 4 49 123 614 626
uva FR940405-1-00137 18 50 93 162 179 209 224 245 273 301 320 331 345 579 615 657 679 730 764
radiation FR940405-1-00137 6 51 129 246 252 302 680
this FR940405-1-00137 2 53 555
uses FR940405-1-00137 1 55
48- FR940405-1-00137 1 56
and FR940405-1-00137 14 57 61 109 148 176 184 226 263 388 407 480 594 705 774
erythema FR940405-1-00137 3 59 346 709
reactions FR940405-1-00137 1 60
12- FR940405-1-00137 1 62
melanogenesis FR940405-1-00137 1 65
skin FR940405-1-00137 6 67 287 377 474 689 702
sensitized FR940405-1-00137 1 68
with FR940405-1-00137 2 69 300
8mop FR940405-1-00137 1 72
however FR940405-1-00137 2 75 711
because FR940405-1-00137 1 77
did FR940405-1-00137 1 80
not FR940405-1-00137 3 81 621 748
have FR940405-1-00137 2 82 379
enough FR940405-1-00137 1 83
information FR940405-1-00137 2 84 177
or FR940405-1-00137 2 85 359
data FR940405-1-00137 3 86 149 174
propose FR940405-1-00137 1 88
for FR940405-1-00137 10 91 121 155 207 285 296 317 417 504 756
determining FR940405-1-00137 3 92 208 318
stated FR940405-1-00137 7 102 306 367 430 610 670 762
should FR940405-1-00137 3 106 766 778
developed FR940405-1-00137 1 108
validated FR940405-1-00137 1 110
same FR940405-1-00137 1 113
manner FR940405-1-00137 1 114
as FR940405-1-00137 4 115 397 622 624
was FR940405-1-00137 1 116
procedure FR940405-1-00137 2 120 269
ultraviolet FR940405-1-00137 2 124 251
b FR940405-1-00137 1 125
uvb FR940405-1-00137 6 127 505 566 627 642 772
ie FR940405-1-00137 2 131 248
factor FR940405-1-00137 1 135
spf FR940405-1-00137 1 137
furthermore FR940405-1-00137 1 142
requested FR940405-1-00137 1 146
comments FR940405-1-00137 3 147 172 290
regarding FR940405-1-00137 4 150 178 204 313
an FR940405-1-00137 2 151 314
appropriate FR940405-1-00137 4 152 223 293 749
methodology FR940405-1-00137 1 154
otc FR940405-1-00137 1 156
products FR940405-1-00137 1 159
afford FR940405-1-00137 1 161
received FR940405-1-00137 1 167
substantial FR940405-1-00137 1 169
amount FR940405-1-00137 1 170
of FR940405-1-00137 14 171 222 244 362 375 385 435 439 484 649 663 687 701 728
ingredients FR940405-1-00137 2 180 225
claims FR940405-1-00137 2 182 227
procedures FR940405-1-00137 2 186 206
after FR940405-1-00137 1 188
evaluating FR940405-1-00137 1 189
submitted FR940405-1-00137 2 191 595
material FR940405-1-00137 1 192
finds FR940405-1-00137 1 196
there FR940405-1-00137 2 198 717
are FR940405-1-00137 5 199 231 254 732 784
two FR940405-1-00137 1 200
basic FR940405-1-00137 1 201
interrelated FR940405-1-00137 1 202
questions FR940405-1-00137 2 203 230
must FR940405-1-00137 2 212 338
addressed FR940405-1-00137 1 214
before FR940405-1-00137 1 215
can FR940405-1-00137 1 218
complete FR940405-1-00137 1 219
its FR940405-1-00137 2 220 600
assessment FR940405-1-00137 1 221
these FR940405-1-00137 4 229 342 395 737
: FR940405-1-00137 2 232 682
1 FR940405-1-00137 2 234 684
what FR940405-1-00137 1 236
action FR940405-1-00137 10 237 283 294 370 415 425 486 596 722 754
spectrum FR940405-1-00137 11 238 295 416 426 463 498 556 639 723 731 755
best FR940405-1-00137 3 239 270 433
describes FR940405-1-00137 1 240
biological FR940405-1-00137 5 242 259 297 437 488
risk FR940405-1-00137 9 243 298 438 503 521 537 550 652 666
which FR940405-1-00137 3 250 267 726
wavelengths FR940405-1-00137 5 253 567 580 643 783
most FR940405-1-00137 3 255 560 733
likely FR940405-1-00137 1 256
cause FR940405-1-00137 1 258
damage FR940405-1-00137 12 260 288 378 401 419 502 520 536 549 561 651 665
defines FR940405-1-00137 1 271
provided FR940405-1-00137 2 275 322
? FR940405-1-00137 1 281
i. FR940405-1-00137 1 282
spectra FR940405-1-00137 4 284 371 487 597
uvarelated FR940405-1-00137 1 286
several FR940405-1-00137 2 289 369
discussed FR940405-1-00137 1 291
associated FR940405-1-00137 1 299
comment FR940405-1-00137 12 305 366 393 411 429 589 609 630 669 714 743 761
developing FR940405-1-00137 1 310
consensus FR940405-1-00137 1 312
acceptable FR940405-1-00137 1 315
assay FR940405-1-00137 1 316
specific FR940405-1-00137 1 330
effect FR940405-1-00137 1 332
is FR940405-1-00137 9 334 509 525 541 563 616 620 718 747
blocked FR940405-1-00137 1 337
considered FR940405-1-00137 1 340
effects FR940405-1-00137 4 343 361 674 738
include FR940405-1-00137 2 344 681
uvainduced FR940405-1-00137 2 348 694
photosensitivity FR940405-1-00137 1 350
immediate FR940405-1-00137 1 352
pigment FR940405-1-00137 1 353
darkening FR940405-1-00137 1 354
delayed FR940405-1-00137 1 356
tanning FR940405-1-00137 1 357
other FR940405-1-00137 1 360
photodamage FR940405-1-00137 1 363
describing FR940405-1-00137 1 372
different FR940405-1-00137 2 373 386
aspects FR940405-1-00137 2 374 396
solarinduced FR940405-1-00137 1 376
been FR940405-1-00137 2 380 443
determined FR940405-1-00137 1 381
number FR940405-1-00137 1 384
species FR940405-1-00137 1 387
cell FR940405-1-00137 1 389
types FR940405-1-00137 1 390
photocarcinogenesis FR940405-1-00137 1 398
dna FR940405-1-00137 1 400
photoaging FR940405-1-00137 2 403 686
mutagenicity FR940405-1-00137 1 405
immunosuppression FR940405-1-00137 1 408
maintained FR940405-1-00137 2 412 744
each FR940405-1-00137 1 414
uvinduced FR940405-1-00137 1 418
closely FR940405-1-00137 1 420
tracks FR940405-1-00137 1 421
human FR940405-1-00137 2 423 473
erythemal FR940405-1-00137 1 424
summary FR940405-1-00137 1 434
uv FR940405-1-00137 3 440 478 491
light FR940405-1-00137 1 441
has FR940405-1-00137 1 442
published FR940405-1-00137 1 444
commission FR940405-1-00137 1 447
internationale FR940405-1-00137 1 448
de FR940405-1-00137 1 449
l'eclairage FR940405-1-00137 1 450
cie FR940405-1-00137 4 452 461 496 637
3 FR940405-1-00137 2 457 698
hazard FR940405-1-00137 3 462 497 638
embodies FR940405-1-00137 1 464
comprehensive FR940405-1-00137 1 466
yet FR940405-1-00137 1 468
normal FR940405-1-00137 1 469
risks FR940405-1-00137 1 471
due FR940405-1-00137 1 475
fullspectrum FR940405-1-00137 1 477
exposure FR940405-1-00137 1 479
reflects FR940405-1-00137 1 481
findings FR940405-1-00137 1 483
responses FR940405-1-00137 1 489
above FR940405-1-00137 1 493
shows FR940405-1-00137 2 499 557
290 FR940405-1-00137 2 507 569
nm FR940405-1-00137 8 508 517 524 533 540 553 572 585
100 FR940405-1-00137 2 510 526
times FR940405-1-00137 3 511 527 545
higher FR940405-1-00137 2 512 528
than FR940405-1-00137 3 513 529 547
320 FR940405-1-00137 5 516 523 539 571 582
400 FR940405-1-00137 1 532
least FR940405-1-00137 1 543
10 FR940405-1-00137 1 544
greater FR940405-1-00137 1 546
340 FR940405-1-00137 2 552 584
potential FR940405-1-00137 1 562
followed FR940405-1-00137 1 575
shorter FR940405-1-00137 1 578
cited FR940405-1-00137 1 590
numerous FR940405-1-00137 1 591
scientific FR940405-1-00137 1 592
articles FR940405-1-00137 1 593
support FR940405-1-00137 1 599
statements FR940405-1-00137 1 601
4 FR940405-1-00137 2 605 707
another FR940405-1-00137 1 608
although FR940405-1-00137 1 612
important FR940405-1-00137 3 617 623 786
it FR940405-1-00137 2 619 746
argued FR940405-1-00137 1 631
based FR940405-1-00137 1 634
on FR940405-1-00137 2 635 675
contribute FR940405-1-00137 1 644
80 FR940405-1-00137 1 645
85 FR940405-1-00137 1 647
percent FR940405-1-00137 2 648 662
sunlight FR940405-1-00137 1 654
while FR940405-1-00137 1 656
contributes FR940405-1-00137 1 658
15 FR940405-1-00137 1 659
20 FR940405-1-00137 1 661
some FR940405-1-00137 1 672
known FR940405-1-00137 2 673 721
humans FR940405-1-00137 1 676
caused FR940405-1-00137 1 677
hypersensitivities FR940405-1-00137 1 695
augmentation FR940405-1-00137 1 700
cancers FR940405-1-00137 1 703
noted FR940405-1-00137 1 715
no FR940405-1-00137 1 719
single FR940405-1-00137 1 720
describe FR940405-1-00137 1 725
parts FR940405-1-00137 1 727
active FR940405-1-00137 1 734
causing FR940405-1-00137 1 736
therefore FR940405-1-00137 1 740
use FR940405-1-00137 1 751
uvaerythema FR940405-1-00137 1 753
purposes FR940405-1-00137 1 758
assessed FR940405-1-00137 1 768
relation FR940405-1-00137 1 770
assumption FR940405-1-00137 1 777
made FR940405-1-00137 1 780
all FR940405-1-00137 1 782
equally FR940405-1-00137 1 785
one FR940405-1-00138 3 0 111 583
comment FR940405-1-00138 8 1 34 65 94 112 189 584 620
stated FR940405-1-00138 3 2 95 434
that FR940405-1-00138 16 3 36 67 96 114 203 346 387 435 468 475 497 502 521 551 593
the FR940405-1-00138 44 4 16 33 38 54 64 68 97 115 145 180 188 191 204 239 249 256 263 271 277 283 288 296 311 332 350 410 422 432 444 448 465 486 490 508 511 517 535 560 619 630 635 648 652
`` FR940405-1-00138 2 5 399
current FR940405-1-00138 2 6 653
test FR940405-1-00138 5 7 14 43 580 591
for FR940405-1-00138 12 8 15 44 194 235 318 417 426 452 546 604 608
erythema FR940405-1-00138 4 9 23 39 312
'' FR940405-1-00138 2 10 402
is FR940405-1-00138 9 11 24 77 81 101 233 310 324 388
inadequate FR940405-1-00138 1 12
to FR940405-1-00138 16 13 42 84 122 126 151 155 211 281 301 356 368 390 506 567 618
full FR940405-1-00138 1 17
spectrum FR940405-1-00138 18 18 41 76 100 107 118 147 193 207 258 314 328 335 401 633 645 650 656
of FR940405-1-00138 12 19 29 53 56 103 179 255 273 492 510 587 634
uva FR940405-1-00138 23 20 30 45 57 90 108 240 257 274 306 319 352 364 374 394 407 419 483 499 532 554 569 606
radiation FR940405-1-00138 9 21 275 307 395 456 484 500 533 555
because FR940405-1-00138 3 22 79 178
not FR940405-1-00138 5 25 361 413 529 595
a FR940405-1-00138 17 26 50 61 104 131 160 215 244 342 383 398 415 436 476 493 522 643
valid FR940405-1-00138 1 27
measurement FR940405-1-00138 1 28
exposure FR940405-1-00138 1 31
. FR940405-1-00138 21 32 63 92 110 141 144 174 177 223 226 276 406 431 464 485 516 534 556 582 613 616
argued FR940405-1-00138 1 35
using FR940405-1-00138 1 37
action FR940405-1-00138 11 40 75 99 117 146 192 206 293 313 327 334
protection FR940405-1-00138 8 46 58 241 392 420 453 481 607
will FR940405-1-00138 1 47
give FR940405-1-00138 1 48
consumers FR940405-1-00138 4 49 266 348 380
false FR940405-1-00138 1 51
sense FR940405-1-00138 1 52
extent FR940405-1-00138 1 55
afforded FR940405-1-00138 1 59
by FR940405-1-00138 5 60 243 262 305 646
product FR940405-1-00138 7 62 247 264 345 386 478 637
added FR940405-1-00138 1 66
immediate FR940405-1-00138 1 69
pigment FR940405-1-00138 1 70
darkening FR940405-1-00138 1 71
( FR940405-1-00138 12 72 139 168 172 221 329 354 366 457 611 626 639
ipd FR940405-1-00138 6 73 98 116 195 205 333
) FR940405-1-00138 12 74 143 171 176 225 336 359 371 463 615 628 641
preferable FR940405-1-00138 1 78
it FR940405-1-00138 1 80
broad FR940405-1-00138 4 82 106 132 400
enough FR940405-1-00138 1 83
take FR940405-1-00138 1 85
into FR940405-1-00138 1 86
account FR940405-1-00138 1 87
almost FR940405-1-00138 1 88
all FR940405-1-00138 1 89
wavelengths FR940405-1-00138 3 91 353 365
another FR940405-1-00138 1 93
indicative FR940405-1-00138 1 102
true FR940405-1-00138 1 105
response FR940405-1-00138 2 109 558
noted FR940405-1-00138 2 113 467
was FR940405-1-00138 2 119 148
first FR940405-1-00138 1 120
described FR940405-1-00138 2 121 150
extend FR940405-1-00138 2 123 152
from FR940405-1-00138 4 124 153 209 382
300 FR940405-1-00138 2 125 154
420 FR940405-1-00138 1 127
nm FR940405-1-00138 9 128 138 157 167 200 213 220 358 370
, FR940405-1-00138 10 129 158 187 248 322 559 572 621 638 657
with FR940405-1-00138 6 130 159 214 228 299 651
peak FR940405-1-00138 3 133 161 217
between FR940405-1-00138 4 134 163 182 196
340 FR940405-1-00138 4 135 219 357 367
and FR940405-1-00138 11 136 165 198 201 441 501 514 539 564 577 658
370 FR940405-1-00138 1 137
ref FR940405-1-00138 4 140 173 222 612
5 FR940405-1-00138 1 142
later FR940405-1-00138 1 149
620 FR940405-1-00138 1 156
effectiveness FR940405-1-00138 1 162
400 FR940405-1-00138 4 164 199 212 369
500 FR940405-1-00138 1 166
visible FR940405-1-00138 1 169
light FR940405-1-00138 2 170 602
6 FR940405-1-00138 1 175
difference FR940405-1-00138 1 181
these FR940405-1-00138 1 183
two FR940405-1-00138 1 184
reported FR940405-1-00138 2 185 202
spectra FR940405-1-00138 2 186 294
reevaluated FR940405-1-00138 1 190
310 FR940405-1-00138 1 197
extends FR940405-1-00138 1 208
320 FR940405-1-00138 2 210 355
low FR940405-1-00138 1 216
around FR940405-1-00138 1 218
7 FR940405-1-00138 1 224
concurrent FR940405-1-00138 1 227
determining FR940405-1-00138 4 229 418 605 629
which FR940405-1-00138 2 230 292
testing FR940405-1-00138 6 231 408 450 512 544 570
procedure FR940405-1-00138 3 232 451 513
appropriate FR940405-1-00138 3 234 338 543
use FR940405-1-00138 2 236 491
in FR940405-1-00138 7 237 421 443 557 575 578 589
validating FR940405-1-00138 1 238
provided FR940405-1-00138 1 242
sunscreen FR940405-1-00138 10 245 343 384 403 428 449 495 523 548 636
drug FR940405-1-00138 5 246 344 385 429 549
agency FR940405-1-00138 7 250 278 411 433 466 536 561
must FR940405-1-00138 1 251
determine FR940405-1-00138 1 252
what FR940405-1-00138 2 253 378
portion FR940405-1-00138 1 254
should FR940405-1-00138 6 259 379 438 472 488 519
be FR940405-1-00138 3 260 439 504
blocked FR940405-1-00138 1 261
before FR940405-1-00138 1 265
are FR940405-1-00138 2 267 295
effectively FR940405-1-00138 1 268
protected FR940405-1-00138 1 269
against FR940405-1-00138 8 270 349 362 393 454 482 531 553
hazards FR940405-1-00138 1 272
would FR940405-1-00138 1 279
like FR940405-1-00138 1 280
consider FR940405-1-00138 1 282
following FR940405-1-00138 1 284
specific FR940405-1-00138 1 285
questions FR940405-1-00138 1 286
at FR940405-1-00138 2 287 461
meeting FR940405-1-00138 1 289
: FR940405-1-00138 2 290 625
1. FR940405-1-00138 1 291
most FR940405-1-00138 1 297
important FR940405-1-00138 1 298
respect FR940405-1-00138 1 300
skin FR940405-1-00138 2 302 610
damage FR940405-1-00138 2 303 375
caused FR940405-1-00138 1 304
? FR940405-1-00138 4 308 339 376 404
2. FR940405-1-00138 1 309
an FR940405-1-00138 3 315 542 588
adequate FR940405-1-00138 1 316
surrogate FR940405-1-00138 1 317
biological FR940405-1-00138 1 320
risk FR940405-1-00138 1 321
or FR940405-1-00138 4 323 396 527 600
some FR940405-1-00138 1 325
other FR940405-1-00138 1 326
such FR940405-1-00138 2 330 470
as FR940405-1-00138 3 331 397 447
more FR940405-1-00138 1 337
3. FR940405-1-00138 1 340
can FR940405-1-00138 2 341 503
protects FR940405-1-00138 1 347
shorter FR940405-1-00138 1 351
but FR940405-1-00138 1 360
longer FR940405-1-00138 1 363
prevent FR940405-1-00138 1 372
significant FR940405-1-00138 2 373 480
4. FR940405-1-00138 1 377
expect FR940405-1-00138 1 381
labeled FR940405-1-00138 1 389
provide FR940405-1-00138 1 391
ii FR940405-1-00138 1 405
procedures FR940405-1-00138 2 409 571
did FR940405-1-00138 1 412
propose FR940405-1-00138 1 414
method FR940405-1-00138 8 416 437 471 487 518 545 592 623
tentative FR940405-1-00138 1 423
final FR940405-1-00138 1 424
monograph FR940405-1-00138 1 425
otc FR940405-1-00138 2 427 547
products FR940405-1-00138 2 430 550
developed FR940405-1-00138 1 440
validated FR940405-1-00138 1 442
same FR940405-1-00138 1 445
manner FR940405-1-00138 1 446
uvb FR940405-1-00138 1 455
58 FR940405-1-00138 1 458
fr FR940405-1-00138 1 459
28194 FR940405-1-00138 1 460
28250 FR940405-1-00138 1 462
any FR940405-1-00138 1 469
clearly FR940405-1-00138 1 473
demonstrate FR940405-1-00138 2 474 520
particular FR940405-1-00138 1 477
provides FR940405-1-00138 1 479
include FR940405-1-00138 1 489
control FR940405-1-00138 1 494
preparation FR940405-1-00138 1 496
absorbs FR940405-1-00138 1 498
used FR940405-1-00138 1 505
assure FR940405-1-00138 1 507
reliability FR940405-1-00138 1 509
equipment FR940405-1-00138 1 515
ingredient FR940405-1-00138 1 524
either FR940405-1-00138 2 525 598
does FR940405-1-00138 3 526 528 594
protect FR940405-1-00138 2 530 552
requested FR940405-1-00138 1 537
comments FR940405-1-00138 1 538
data FR940405-1-00138 2 540 565
regarding FR940405-1-00138 1 541
received FR940405-1-00138 1 562
information FR940405-1-00138 1 563
pertaining FR940405-1-00138 1 566
several FR940405-1-00138 1 568
including FR940405-1-00138 1 573
both FR940405-1-00138 1 574
vivo FR940405-1-00138 1 576
vitro FR940405-1-00138 2 579 590
methods FR940405-1-00138 1 581
recommended FR940405-1-00138 1 585
adoption FR940405-1-00138 1 586
rely FR940405-1-00138 1 596
upon FR940405-1-00138 1 597
photosensitization FR940405-1-00138 1 599
nonsolar FR940405-1-00138 1 601
sources FR940405-1-00138 1 603
normal FR940405-1-00138 1 609
8 FR940405-1-00138 1 614
according FR940405-1-00138 1 617
this FR940405-1-00138 1 622
involves FR940405-1-00138 1 624
1 FR940405-1-00138 1 627
uv FR940405-1-00138 1 631
absorbance FR940405-1-00138 1 632
2 FR940405-1-00138 1 640
calculating FR940405-1-00138 1 642
convolution FR940405-1-00138 1 644
multiplying FR940405-1-00138 1 647
solar FR940405-1-00138 1 649
cie FR940405-1-00138 1 654
hazard FR940405-1-00138 1 655
( FR940405-1-00139 17 0 27 49 176 204 215 243 282 294 316 450 497 606 620 813 985 1018
3 FR940405-1-00139 2 1 216
) FR940405-1-00139 17 2 29 54 178 206 217 245 284 296 318 459 502 610 640 817 989 1022
incorporating FR940405-1-00139 1 3
the FR940405-1-00139 92 4 9 31 40 43 60 65 78 84 90 101 106 123 129 133 141 144 160 172 184 248 258 300 328 333 341 348 363 380 392 397 401 410 414 420 436 483 493 510 520 525 532 540 544 553 561 565 571 575 583 614 635 638 643 647 656 675 715 719 745 751 755 759 765 771 775 780 792 806 837 841 860 864 870 873 888 895 914 921 926 932 937 947 961 969 975 996 1003 1006 1024 1028 1041
sunscreen FR940405-1-00139 11 5 188 223 545 576 652 691 708 798 902 966
transmission FR940405-1-00139 2 6 677
spectrum FR940405-1-00139 9 7 11 47 69 126 404 416 527 776
into FR940405-1-00139 1 8
convolution FR940405-1-00139 1 10
to FR940405-1-00139 29 12 51 77 89 121 170 196 274 278 323 340 370 372 386 465 499 519 531 570 588 632 670 714 779 886 893 909 959 1002
obtain FR940405-1-00139 1 13
a FR940405-1-00139 26 14 23 57 98 166 181 222 336 352 373 406 431 651 682 703 711 732 748 797 846 867 878 883 954 965 972
uva FR940405-1-00139 20 15 24 48 230 240 265 276 301 342 355 411 424 537 541 766 793 874 896 917 944
effectiveness FR940405-1-00139 3 16 326 573
ratio FR940405-1-00139 6 17 753 757 784 1000 1010
which FR940405-1-00139 2 18 270
is FR940405-1-00139 15 19 97 119 180 235 286 320 347 368 439 463 517 697 731 1033
conveniently FR940405-1-00139 1 20
expressed FR940405-1-00139 1 21
as FR940405-1-00139 8 22 309 661 788 822 824 850 923
protection FR940405-1-00139 7 25 228 241 356 794 875 918
percentage FR940405-1-00139 1 26
app FR940405-1-00139 12 28 41 85 130 145 173 345 366 398 437 488 566
. FR940405-1-00139 34 30 59 105 137 159 327 358 391 430 452 482 509 539 558 592 608 655 693 721 741 754 777 801 815 836 859 901 931 968 987 990 1020 1023 1056
comment FR940405-1-00139 20 32 61 107 161 329 360 393 433 485 562 594 657 781 803 838 861 933 970 992 1025
maintained FR940405-1-00139 1 33
that FR940405-1-00139 25 34 63 109 163 331 362 379 395 435 461 474 487 503 564 596 629 706 769 805 840 863 882 935 1027 1040
, FR940405-1-00139 28 35 39 83 117 139 151 192 194 232 254 257 267 344 417 454 456 460 472 560 578 622 728 782 821 827 829 852 854
unlike FR940405-1-00139 1 36
other FR940405-1-00139 1 37
methods FR940405-1-00139 2 38 619
represents FR940405-1-00139 1 42
fraction FR940405-1-00139 1 44
of FR940405-1-00139 39 45 100 143 168 183 250 260 288 335 351 409 413 423 543 574 585 613 616 624 637 646 650 678 684 718 747 761 774 791 796 872 898 916 964 974 998 1005 1011 1030
full FR940405-1-00139 2 46 68
320 FR940405-1-00139 2 50 498
400 FR940405-1-00139 4 52 500 671 739
nm FR940405-1-00139 5 53 501 666 672 740
removed FR940405-1-00139 1 55
by FR940405-1-00139 9 56 427 602 809 877 920 925 1035 1046
product FR940405-1-00139 11 58 225 325 353 577 654 749 800 879 967 1037
stated FR940405-1-00139 4 62 361 595 862
because FR940405-1-00139 2 64 396
original FR940405-1-00139 1 66
`` FR940405-1-00139 3 67 938 980
'' FR940405-1-00139 3 70 940 982
method FR940405-1-00139 13 71 600 660 743 807 842 865 892 930 956 1001 1032 1048
produces FR940405-1-00139 1 72
an FR940405-1-00139 5 73 111 197 597 789
spf FR940405-1-00139 15 74 81 91 103 112 186 448 507 512 523 535 556 746 948 1007
value FR940405-1-00139 2 75 513
analogous FR940405-1-00139 1 76
clinically FR940405-1-00139 2 79 116
determined FR940405-1-00139 4 80 92 115 924
number FR940405-1-00139 2 82 167
has FR940405-1-00139 5 86 113 567 702 818
direct FR940405-1-00139 4 87 156 305 568
relevance FR940405-1-00139 2 88 569
on FR940405-1-00139 4 93 132 155 476
human FR940405-1-00139 5 94 264 279 374 586
subjects FR940405-1-00139 2 95 587
and FR940405-1-00139 31 96 127 191 233 268 307 315 378 405 443 457 473 524 604 626 641 673 689 701 738 750 811 830 880 890 928 946 979 1008 1014 1039
subset FR940405-1-00139 2 99 182
fullspectrum FR940405-1-00139 2 102 124
determination FR940405-1-00139 4 104 142 346 1004
added FR940405-1-00139 5 108 330 394 486 881
once FR940405-1-00139 1 110
been FR940405-1-00139 2 114 480
it FR940405-1-00139 12 118 152 179 207 218 234 246 285 297 319 418 462
simple FR940405-1-00139 4 120 464 826 955
take FR940405-1-00139 1 122
absorbance FR940405-1-00139 2 125 526
calculate FR940405-1-00139 1 128
based FR940405-1-00139 1 131
clinical FR940405-1-00139 7 134 157 212 515 534 572 834
test FR940405-1-00139 4 135 367 381 399
results FR940405-1-00139 2 136 1044
therefore FR940405-1-00139 3 138 193 559
although FR940405-1-00139 1 140
does FR940405-1-00139 4 146 208 580 843
involve FR940405-1-00139 1 147
in FR940405-1-00139 20 148 200 237 303 311 332 364 375 446 505 521 554 598 617 664 710 764 770 1042 1053
vitro FR940405-1-00139 8 149 365 447 506 522 555 599 1043
measurements FR940405-1-00139 2 150 158
also FR940405-1-00139 1 153
relies FR940405-1-00139 1 154
contended FR940405-1-00139 1 162
there FR940405-1-00139 2 164 730
are FR940405-1-00139 2 165 490
advantages FR940405-1-00139 2 169 820
using FR940405-1-00139 3 171 469 936
system FR940405-1-00139 3 174 942 984
: FR940405-1-00139 1 175
1 FR940405-1-00139 1 177
existing FR940405-1-00139 1 185
for FR940405-1-00139 7 187 263 536 869 943 950 957
drug FR940405-1-00139 4 189 224 653 799
products FR940405-1-00139 6 190 429 709 900 903 922
relates FR940405-1-00139 1 195
erythemal FR940405-1-00139 1 198
endpoint FR940405-1-00139 2 199 848
normal FR940405-1-00139 1 201
skin FR940405-1-00139 3 202 280 720
; FR940405-1-00139 6 203 214 242 281 293 314
2 FR940405-1-00139 1 205
not FR940405-1-00139 5 209 272 383 581 844
unnecessarily FR940405-1-00139 1 210
duplicate FR940405-1-00139 1 211
testing FR940405-1-00139 2 213 835
clearly FR940405-1-00139 1 219
demonstrates FR940405-1-00139 1 220
whether FR940405-1-00139 1 221
provides FR940405-1-00139 3 226 866 953
meaningful FR940405-1-00139 1 227
against FR940405-1-00139 1 229
radiation FR940405-1-00139 7 231 425 591 680 699 723 763
useful FR940405-1-00139 1 236
determining FR940405-1-00139 1 238
comparative FR940405-1-00139 1 239
4 FR940405-1-00139 1 244
avoids FR940405-1-00139 2 247 611
deficiencies FR940405-1-00139 1 249
nonsolar FR940405-1-00139 1 251
light FR940405-1-00139 3 252 337 627
sources FR940405-1-00139 2 253 628
photosensitizing FR940405-1-00139 1 255
chemicals FR940405-1-00139 1 256
failure FR940405-1-00139 1 259
dose FR940405-1-00139 2 261 290
reciprocity FR940405-1-00139 2 262 625
exposures FR940405-1-00139 1 266
endpoints FR940405-1-00139 1 269
do FR940405-1-00139 1 271
relate FR940405-1-00139 1 273
known FR940405-1-00139 1 275
damage FR940405-1-00139 1 277
5 FR940405-1-00139 3 283 631 665
independent FR940405-1-00139 1 287
exposure FR940405-1-00139 2 289 584
or FR940405-1-00139 3 291 389 855
duration FR940405-1-00139 1 292
6 FR940405-1-00139 1 295
includes FR940405-1-00139 1 298
all FR940405-1-00139 1 299
wavelengths FR940405-1-00139 1 302
their FR940405-1-00139 1 304
proportion FR940405-1-00139 1 306
intensity FR940405-1-00139 2 308 636
found FR940405-1-00139 1 310
natural FR940405-1-00139 1 312
sunlight FR940405-1-00139 1 313
7 FR940405-1-00139 1 317
directly FR940405-1-00139 1 321
relevant FR940405-1-00139 1 322
overall FR940405-1-00139 1 324
absence FR940405-1-00139 1 334
source FR940405-1-00139 2 338 724
specific FR940405-1-00139 1 339
range FR940405-1-00139 1 343
best FR940405-1-00139 1 349
measurement FR940405-1-00139 1 350
's FR940405-1-00139 3 354 546 977
level FR940405-1-00139 1 357
one FR940405-1-00139 4 359 593 802 908
difficult FR940405-1-00139 1 369
extend FR940405-1-00139 1 371
vivo FR940405-1-00139 3 376 618 1054
situation FR940405-1-00139 1 377
can FR940405-1-00139 4 382 528 548 785
be FR940405-1-00139 6 384 529 550 726 786 905
used FR940405-1-00139 3 385 727 787
study FR940405-1-00139 1 387
substantivity FR940405-1-00139 1 388
stability FR940405-1-00139 1 390
uses FR940405-1-00139 1 400
erythema FR940405-1-00139 2 402 851
action FR940405-1-00139 1 403
mathematical FR940405-1-00139 1 407
extraction FR940405-1-00139 1 408
segment FR940405-1-00139 1 412
solar FR940405-1-00139 1 415
overestimates FR940405-1-00139 1 419
actual FR940405-1-00139 1 421
amount FR940405-1-00139 2 422 915
blocked FR940405-1-00139 1 426
most FR940405-1-00139 1 428
reply FR940405-1-00139 2 432 484
argued FR940405-1-00139 2 434 563
technique FR940405-1-00139 1 438
derived FR940405-1-00139 2 440 491
from FR940405-1-00139 5 441 492 514 552 668
wellstudied FR940405-1-00139 1 442
extensively FR940405-1-00139 1 444
published FR940405-1-00139 2 445 481
methodology FR940405-1-00139 2 449 978
refs FR940405-1-00139 1 451
9 FR940405-1-00139 1 453
10 FR940405-1-00139 1 455
11 FR940405-1-00139 1 458
evaluate FR940405-1-00139 1 466
water FR940405-1-00139 2 467 477
resistance FR940405-1-00139 2 468 478
this FR940405-1-00139 7 470 659 742 783 999 1031 1047
model FR940405-1-00139 1 471
data FR940405-1-00139 4 475 496 557 994
have FR940405-1-00139 1 479
values FR940405-1-00139 3 489 508 1055
same FR940405-1-00139 1 494
spectral FR940405-1-00139 2 495 676
provide FR940405-1-00139 1 504
final FR940405-1-00139 1 511
studies FR940405-1-00139 1 516
compared FR940405-1-00139 1 518
matched FR940405-1-00139 1 530
exact FR940405-1-00139 1 533
calculations FR940405-1-00139 1 538
portion FR940405-1-00139 1 542
efficacy FR940405-1-00139 1 547
then FR940405-1-00139 1 549
calculated FR940405-1-00139 1 551
but FR940405-1-00139 1 579
require FR940405-1-00139 2 582 845
unnecessary FR940405-1-00139 1 589
uv FR940405-1-00139 4 590 679 698 762
developed FR940405-1-00139 2 601 808
diffey FR940405-1-00139 4 603 810 889 927
robson FR940405-1-00139 4 605 812 891 929
ref FR940405-1-00139 4 607 814 986 1019
12 FR940405-1-00139 2 609 816
many FR940405-1-00139 2 612 819
limitations FR940405-1-00139 1 615
eg FR940405-1-00139 1 621
lack FR940405-1-00139 1 623
produce FR940405-1-00139 1 630
20 FR940405-1-00139 1 633
times FR940405-1-00139 1 634
sun FR940405-1-00139 1 639
allows FR940405-1-00139 1 642
correct FR940405-1-00139 1 644
estimation FR940405-1-00139 1 645
attenuating FR940405-1-00139 1 648
power FR940405-1-00139 2 649 734
described FR940405-1-00139 1 658
recording FR940405-1-00139 1 662
photocurrent FR940405-1-00139 1 663
steps FR940405-1-00139 1 667
290 FR940405-1-00139 2 669 737
measuring FR940405-1-00139 1 674
through FR940405-1-00139 1 681
sample FR940405-1-00139 1 683
transpore FR940405-1-00139 2 685 694
tm FR940405-1-00139 2 686 695
tape FR940405-1-00139 2 687 696
with FR940405-1-00139 5 688 768 833 907 1052
without FR940405-1-00139 1 690
applied FR940405-1-00139 1 692
transparent FR940405-1-00139 1 700
rough FR940405-1-00139 1 704
surface FR940405-1-00139 2 705 717
distributes FR940405-1-00139 1 707
way FR940405-1-00139 1 712
similar FR940405-1-00139 1 713
uneven FR940405-1-00139 1 716
any FR940405-1-00139 1 722
may FR940405-1-00139 1 725
providing FR940405-1-00139 1 729
continuous FR940405-1-00139 1 733
distribution FR940405-1-00139 1 735
between FR940405-1-00139 1 736
assesses FR940405-1-00139 1 744
uva/uvb FR940405-1-00139 3 752 756 1009
compares FR940405-1-00139 1 758
reduction FR940405-1-00139 1 760
region FR940405-1-00139 2 767 773
uvb FR940405-1-00139 2 772 951
according FR940405-1-00139 1 778
indicator FR940405-1-00139 1 790
properties FR940405-1-00139 1 795
claimed FR940405-1-00139 1 804
well FR940405-1-00139 2 823 831
being FR940405-1-00139 1 825
inexpensive FR940405-1-00139 1 828
correlated FR940405-1-00139 1 832
noted FR940405-1-00139 2 839 1026
biological FR940405-1-00139 1 847
such FR940405-1-00139 1 849
tanning FR940405-1-00139 1 853
immediate FR940405-1-00139 1 856
pigment FR940405-1-00139 1 857
darkening FR940405-1-00139 1 858
basis FR940405-1-00139 1 868
classification FR940405-1-00139 1 871
provided FR940405-1-00139 2 876 919
manufacturer FR940405-1-00139 2 884 976
planned FR940405-1-00139 1 885
utilize FR940405-1-00139 1 887
standardize FR940405-1-00139 1 894
claims FR940405-1-00139 3 897 945 952
its FR940405-1-00139 1 899
would FR940405-1-00139 1 904
labeled FR940405-1-00139 1 906
four FR940405-1-00139 1 910
stars FR940405-1-00139 1 911
depending FR940405-1-00139 1 912
upon FR940405-1-00139 1 913
concluded FR940405-1-00139 1 934
star FR940405-1-00139 2 939 981
rating FR940405-1-00139 2 941 983
designation FR940405-1-00139 1 949
consumers FR940405-1-00139 1 958
determine FR940405-1-00139 1 960
protective FR940405-1-00139 1 962
nature FR940405-1-00139 1 963
submitted FR940405-1-00139 2 971 993
description FR940405-1-00139 1 973
13 FR940405-1-00139 1 988
another FR940405-1-00139 1 991
describing FR940405-1-00139 1 995
application FR940405-1-00139 2 997 1038
titanium FR940405-1-00139 1 1012
dioxide FR940405-1-00139 1 1013
zinc FR940405-1-00139 1 1015
oxide FR940405-1-00139 1 1016
dispersions FR940405-1-00139 1 1017
14 FR940405-1-00139 1 1021
accuracy FR940405-1-00139 1 1029
enhanced FR940405-1-00139 1 1034
good FR940405-1-00139 2 1036 1050
obtained FR940405-1-00139 1 1045
show FR940405-1-00139 1 1049
agreement FR940405-1-00139 1 1051
however FR940405-1-00140 1 0
, FR940405-1-00140 3 1 94 134
another FR940405-1-00140 1 2
comment FR940405-1-00140 3 3 33 136
contended FR940405-1-00140 1 4
that FR940405-1-00140 2 5 35
the FR940405-1-00140 14 6 32 36 45 59 82 88 95 106 111 122 126 130 135
diffey FR940405-1-00140 2 7 37
and FR940405-1-00140 2 8 38
robson FR940405-1-00140 2 9 39
method FR940405-1-00140 3 10 40 99
( FR940405-1-00140 3 11 26 69
ref FR940405-1-00140 3 12 27 70
. FR940405-1-00140 7 13 28 31 71 74 110 132
12 FR940405-1-00140 1 14
) FR940405-1-00140 3 15 30 73
has FR940405-1-00140 2 16 41
been FR940405-1-00140 2 17 42
shown FR940405-1-00140 1 18
to FR940405-1-00140 2 19 125
have FR940405-1-00140 1 20
poor FR940405-1-00140 1 21
correlation FR940405-1-00140 1 22
with FR940405-1-00140 1 23
clinical FR940405-1-00140 1 24
results FR940405-1-00140 2 25 116
15 FR940405-1-00140 1 29
stated FR940405-1-00140 1 34
used FR940405-1-00140 1 43
as FR940405-1-00140 4 44 54 81 104
basis FR940405-1-00140 1 46
for FR940405-1-00140 2 47 92
`` FR940405-1-00140 4 48 55 96 112
quantifying FR940405-1-00140 1 49
'' FR940405-1-00140 4 50 57 98 114
uva FR940405-1-00140 3 51 102 123
protection FR940405-1-00140 1 52
expressed FR940405-1-00140 1 53
stars FR940405-1-00140 1 56
on FR940405-1-00140 1 58
package FR940405-1-00140 1 60
labeling FR940405-1-00140 1 61
of FR940405-1-00140 3 62 121 129
some FR940405-1-00140 1 63
sunscreen FR940405-1-00140 1 64
products FR940405-1-00140 1 65
sold FR940405-1-00140 1 66
in FR940405-1-00140 1 67
europe FR940405-1-00140 1 68
16 FR940405-1-00140 1 72
without FR940405-1-00140 1 75
using FR940405-1-00140 1 76
an FR940405-1-00140 2 77 118
action FR940405-1-00140 1 78
spectrum FR940405-1-00140 3 79 86 91
such FR940405-1-00140 1 80
cie FR940405-1-00140 1 83
uv FR940405-1-00140 1 84
hazard FR940405-1-00140 1 85
or FR940405-1-00140 1 87
erythemal FR940405-1-00140 2 89 108
efficacy FR940405-1-00140 1 90
weighting FR940405-1-00140 1 93
star FR940405-1-00140 2 97 113
considers FR940405-1-00140 1 100
all FR940405-1-00140 1 101
wavelengths FR940405-1-00140 1 103
having FR940405-1-00140 1 105
same FR940405-1-00140 1 107
effectiveness FR940405-1-00140 1 109
value FR940405-1-00140 1 115
from FR940405-1-00140 1 117
unweighted FR940405-1-00140 1 119
ratio FR940405-1-00140 1 120
absorbance FR940405-1-00140 2 124 128
uvb FR940405-1-00140 1 127
product FR940405-1-00140 1 131
therefore FR940405-1-00140 1 133
maintained FR940405-1-00140 1 137
